Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA) "PRISM II"

Active, not recruiting

Phase 4 Results N/A

Main Contacts

Name Phone E-mail
Randall Kaye, MD Contact Backup 855-472-2722
Charles D Yonan, PharmD Contact (949) 389-6781 cyonan@avanir.com
Fred Ledon Contact (949) 389-6724 pshin@avanir.com
Paul Shin Contact Backup (949) 268-5930 pshin@avanir.com

Other Locations

Name City State Country Status
Name Unavailable Pensacola Florida United States Unknown_status_icon